Cinacalcet: An oral calcimimetic agent for the managementof hyperparathyroidism
- 30 November 2005
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 27 (11) , 1725-1751
- https://doi.org/10.1016/j.clinthera.2005.11.015
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Challenges in the Therapy of Secondary HyperparathyroidismTherapeutic Apheresis and Dialysis, 2005
- Mineral Metabolism, Mortality, and Morbidity in Maintenance HemodialysisJournal of the American Society of Nephrology, 2004
- The Calcimimetic Cinacalcet Normalizes Serum Calcium in Subjects with Primary HyperparathyroidismJournal of Clinical Endocrinology & Metabolism, 2003
- Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometryCurrent Opinion in Nephrology and Hypertension, 2003
- Association of Elevated Serum PO4, Ca × PO4 Product, and Parathyroid Hormone with Cardiac Mortality Risk in Chronic Hemodialysis PatientsJournal of the American Society of Nephrology, 2001
- Parathyroid CarcinomaJournal of Clinical Endocrinology & Metabolism, 2001
- Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing DialysisNew England Journal of Medicine, 2000
- Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national studyAmerican Journal of Kidney Diseases, 1998
- The importance of dietary calcium and phosphorous in the secondary hyperparathyroidism of patients with early renal failureAmerican Journal of Kidney Diseases, 1997
- Renal OsteodystrophyNew England Journal of Medicine, 1995